Tarsus Pharmaceuticals (TARS) EV to FCF (2021 - 2026)
Tarsus Pharmaceuticals' EV to FCF came in at 44.25 for Q2 2026.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EV to FCF (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tarsus Pharmaceuticals reported EV to FCF of 29.80; for FY2021, it came in at 92.96.
- The Q2 2026 figure represents the highest quarterly EV to FCF since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tarsus Pharmaceuticals | 3.40 Bn | 2.35 Bn | 161.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.25 |
| Dec 31, 2021 | 92.96 |
| Sep 30, 2021 | 46.89 |
API Access
Tarsus Pharmaceuticals EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();